Order by: Title Ascending Title Descending Recent First Oldest First
Published on 16 October 2018 By ESCP Secretariat In Varia
Symposium - Richard Brady (UK), Gianluca Pellino (Italy), Michael Seres (UK), Sam Atallah (USA), Steven Wexner (UK) at ESCP Nice 2018
Published on 12 December 2014 By ESCP Secretariat In Fecal Incontinence
Oral Poster (Functional disorders) - Lluís Mundet at ESCP Barcelona 2014
Published on 04 November 2019 By ESCP Secretariat In Ulcerative Colitis
ESCP/ECCO Symposium - Andre D'Hoore (Belgium) at ESCP Vienna 2019
Published on 04 November 2013 By ESCP Secretariat In Rectal Cancer
Oral poster - Therese Juul at ESCP Belgrade 2013
Published on 29 November 2024 By ESCP Secretariat In Rectal Cancer
Oral visual poster presentation - Robert Siegel (Germany) at ESCP Thessaloniki 2024
Published on 25 November 2015 By ESCP Secretariat In Rectal Cancer
Japanese Visiting Fellow - Kenji Matsuda at ESCP Dublin 2015
Published on 07 August 2014 By ESCP Secretariat In Periop Management
One of the Six Best Papers - Basil D’Souza (Australia) at Tripartite Colorectal Meeting 2014
Oral Poster (Functional disorders) - Craig Rimmer at ESCP Barcelona 2014
Published on 04 November 2013 By ESCP Secretariat In Anorectal Abscess and Fistula
One of the Six Best Papers - Agnes Senéjoux at ESCP Belgrade 2013
Published on 22 September 2020 By ESCP Secretariat In Varia
Top abstract 5 - Quentin Denost (France) at ESCP Virtually Vilnius 2020
Published on 07 August 2014 By ESCP Secretariat In Varia
Symposium - Brendan Moran (UK) at Tripartite Colorectal Meeting 2014
Symposium - Emmanuel Tiret (France) at Tripartite Colorectal Meeting 2014
Symposium - Alexander Heriot (Australia) at Tripartite Colorectal Meeting 2014
Published on 07 August 2014 By ESCP Secretariat In Retrorectal Tumours
Symposium - Janice Rafferty (USA) at Tripartite Colorectal Meeting 2014
Published on 23 November 2023 By ESCP Secretariat In Genetics
ESCP/EHTG joint symposium - Alessandro Manucci (Italy) at ESCP Vilnius 2023
Published on 30 November 2023 By ESCP Secretariat In Rectal Cancer
ESCP/EAES joint symposium - Fred Ris (Swtizerland) at ESCP Vilnius 2023
Published on 25 November 2015 By ESCP Secretariat In Fecal Incontinence
Oral Poster (Proctology and Functional) - Camilla C. Kjeldsen at ESCP Dublin 2015
Published on 09 January 2017 By ESCP Secretariat In Constipation
A video by Marc Possover
Published on 18 May 2017 By European Manual of Medicine: Coloproctology In Rectal Cancer
Rectal cancer should be managed by a multidisciplinary team (MDT) that includes input from gastroenterology, radiology, pathology, radiation oncology, and oncology in addition to colorectal surgery. The workup of suspected rectal cancer includes digital rectal examination, rectoscopy (proctoscopy), and biopsy. Staging of the tumor requires thoracic/abdominal computed tomography, pelvic magnetic resonance imaging, and complete colonoscopy to assess local tumor growth, systemic spread, and synchronous colonic lesions. The findings should be discussed during an MDT conference to determine the optimal sequence of treatment and the timing and extent of surgical resection. Radiotherapy, which is best delivered preoperatively, reduces the risk of local recurrence and may enhance survival in high-risk patients. Concomitant chemotherapy is used to increase the effect of radiotherapy (chemosensitizing radiation). Complete resection of the rectum en bloc with the surrounding mesorectal envelope enclosing draining lymphatic tissue, called total mesorectal excision, is the gold standard to decrease the risk of local recurrence and avoid injury to adjacent pelvic structures. Rectal cancers in the middle and upper third of the rectum can be treated with sphincter-saving anterior resection and colorectal anastomosis. Cancer in the lower third of the rectum may be amenable to low anterior resection with coloanal anastomosis or require abdominoperineal excision. Tumors involving the pelvic floor or external anal sphincter are treated with extralevator abdominoperineal excision and permanent colostomy. Preoperative chemoradiotherapy may result in complete clinical and radiological response. Such patients may enter a watch-and-wait program of intensive surveillance to detect tumor regrowth. Review of the surgical specimen pathology during a postoperative MDT meeting is important to ensure treatment quality and to determine the potential need for adjuvant chemotherapy. Follow-up after treatment, to detect metachronous colorectal cancer, local recurrence, or systemic disease, should continue for 5 years. Surgery and radiotherapy have adverse effects on function of the bowel, urinary bladder, sexual organs, and gonads, which warrant attention both at the onset of treatment and during follow-up.
Published on 12 December 2014 By ESCP Secretariat In Rectal Cancer
Keynote Lecture - Eric Rullier at ESCP Barcelona 2014
Published on 26 October 2022 By ESCP Secretariat In Rectal Cancer
Scientific session - Brendan Moran (UK) at ESCP Dublin 2022
Scientific session - Konstantinos Stamou (Greece) at ESCP Dublin 2022
Scientific session - Seon Hahn Kim (South Korea) at ESCP Dublin 2022
Scientific session - Jim Khan (UK) at ESCP Dublin 2022
Published on 25 November 2015 By ESCP Secretariat In Ulcerative Colitis
Free Papers (IBD) - Maie Abdalla at ESCP Dublin 2015
Free paper - Etienne Buscail at ESCP Belgrade 2013
Quentin Denost (France) at ESCP Vilnius 2023
Published on 23 November 2023 By ESCP Secretariat In Rectal Cancer
Joep Knol (Belgium) at ESCP Vilnius 2023
Felix Aigner (Germany) at ESCP Vilnius 2023
Jim Khan (United Kingdom) at ESCP Vilnius 2023
Please do not use a Yahoo email for your account. If you are using one, change it now.
This site uses cookies to store information on your computer. Read more...
